Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases | Podcast

TrialSite Staff December 23, 2020
1 Comment

Dr. Ragan discusses X4 Pharmaceuticals, which is currently developing therapies for rare genetic diseases that result from dysfunction of the immune system and is currently undergoing a global Phase 3 trial for WHIM Syndrome and two Phase 1b trials for Waldenstrom macroglobulinemia (WM), a type of rare lymphoma, and severe congenital neutropenia (SCN).

X4 Website: https://www.x4pharma.com

X4 Twitter: https://twitter.com/x4pharma

X4 LinkedIn: https://www.linkedin.com/company/x4-pharmaceuticals

PODCAST

Categories: Podcast
Tagged:
TrialSite Staff

Responses

Report Content

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Anything overly promotional selling products or services

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.